🇺🇸 FDA
Pipeline program

Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung, Panzyga 100 mg/ml Infusionslösung

NGAM-12

Phase 3 small_molecule active

Quick answer

Isotone Kochsalz-Lösung 0,9 % Braun Infusionslösung, Panzyga 100 mg/ml Infusionslösung for Primary infection prophylaxis in patients with chronic lymphocytic leukemia (CLL) and secondary hypogammaglobulinemia. is a Phase 3 program (small_molecule) at Maze Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Maze Therapeutics
Indication
Primary infection prophylaxis in patients with chronic lymphocytic leukemia (CLL) and secondary hypogammaglobulinemia.
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials